Drugs / Factor IX Concentrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01128881 | May 2010 → Aug 2012 | hemophilia B | Baxalta now part of Shire | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Factor IX Concentrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01128881 ↗ |
| Modality | Protein / enzyme biologic | “Biological: Factor IX Concentrate (purified, virus-inactivated)” NCT01128881 ↗ |
| Route | Intravenous | “Intravenous injection/infusion” NCT01128881 ↗ |